-
Mashup Score: 0Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID) - 4 year(s) ago
Coronavirus disease 2019 (COVID-19) causes a hypercoagulable state. Several autopsy studies have found microthrombi in pulmonary circulation.
Source: Thrombosis ResearchCategories: Latest Headlines, PulmonologyTweet
-
Mashup Score: 3Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID) - 4 year(s) ago
Coronavirus disease 2019 (COVID-19) causes a hypercoagulable state. Several autopsy studies have found microthrombi in pulmonary circulation.
Source: Thrombosis ResearchCategories: Latest Headlines, PulmonologyTweet-
Therapeutic versus prophylactic anticoagulation for severe #COVID19: https://t.co/UFO1JacBtk
-
-
Mashup Score: 2
An individualised thromboprophylaxis was implemented in critically ill patients suffering from coronavirus disease 2019 (COVID-19) pneumonia to reduce mortality and improve clinical outcome. The aim of this study was to evaluate the effect of this intervention on clinical outcome.
Source: Thrombosis ResearchCategories: Cardiologists, Latest HeadlinesTweet-
RT @AndreasGevaert: https://t.co/daCv3FZvQD @hvanspall @pabeda1 @SABOURETCardio @DrMarthaGulati @mmamas1973 @VerwerftJan @krychtiukmd @Miha…
-
-
Mashup Score: 1
An individualised thromboprophylaxis was implemented in critically ill patients suffering from coronavirus disease 2019 (COVID-19) pneumonia to reduce mortality and improve clinical outcome. The aim of this study was to evaluate the effect of this intervention on clinical outcome.
Source: Thrombosis ResearchCategories: Cardiologists, Latest HeadlinesTweet-
RT @AndreasGevaert: https://t.co/daCv3FZvQD @hvanspall @pabeda1 @SABOURETCardio @DrMarthaGulati @mmamas1973 @VerwerftJan @krychtiukmd @Miha…
-
-
Mashup Score: 3Clinical practice guidelines for the treatment and prevention of cancer-associated thrombosis - 4 year(s) ago
The risk of venous thromboembolism (VTE) is increased in patients with cancer and is greatest in those with cancers of the pancreas, stomach, brain, lung and ovary, late stage disease and in those undergoing treatment including chemotherapy, hormonal therapy, or surgery. VTE in patients with cancer is associated with a variety of adverse consequences including an increased risk of VTE recurrence,…
Source: Thrombosis ResearchCategories: Hem/Oncs, Latest HeadlinesTweet-
#CCC19 #oncoalert Guidelines for the treatment and prevention of cancer-associated thrombosis https://t.co/S3xcVI4wft VTE in cancer pts associated with increased risk of VTE recurrence, major bleeding & early mortality @NicoleKuderer @ICTHIC @ADesaiMD @YLeyfman @COVID19nCCC
-
RT @gary_lyman: #CCC19 #oncoalert Guidelines for the treatment and prevention of cancer-associated thrombosis https://t.co/S3xcVI4wft VTE…
-
-
Mashup Score: 3The gut microbiome and thromboembolism - 4 year(s) ago
The gut microbiome plays a critical role in various inflammatory conditions, and its modulation is a potential treatment option for these conditions. The role of the gut microbiome in the pathogenesis of thromboembolism has not been fully elucidated. In this review, we summarize the evidence linking the gut microbiome to the pathogenesis of arterial and venous thrombosis. In a human host,…
Source: Thrombosis ResearchCategories: Hem/OncsTweet-
Our invited review on the association of gut dysbiosis and several disease states with high risk of thrombosis is out. Stay tuned for the results of our recently completed study #leakygut #VTE @ThrombosisRese1 "The gut microbiome and thromboembolism" https://t.co/KQH6IODaAD
-
-
Mashup Score: 0Differential features in composition of coronary thrombus of women with ST-segment elevation myocardial infarction - 4 year(s) ago
To characterize sex differences in the composition of coronary thrombus in patients with ST-segment elevation myocardial infarction (STEMI), especially in the young (age ≤ 55 years).
Source: Thrombosis ResearchCategories: CardiologistsTweet-
🔺Coronary Thrombi from young women age ≤ 55 with #STEMI showed a lower content of fibrin, p-selectin & vWF than those from men 🔺Different biological mechanisms b/w sexes in acute coronary syndromes #ACCWIC https://t.co/zjloCqDe9T https://t.co/J5eZqjNdC9 https://t.co/1X4jb5RYjv
-
-
Mashup Score: 4Short-term prognosis of breakthrough venous thromboembolism in anticoagulated patients - 4 year(s) ago
Evidence for guideline recommendations for the treatment of venous thromboembolism (VTE) during anticoagulant therapy is scarce. We aimed to observe and to describe the management of VTE occurring during anticoagulant therapy.
Source: Thrombosis ResearchCategories: Hem/OncsTweet-
Short-term prognosis of breakthrough venous thromboembolism in anticoagulated patients. Open access! https://t.co/Lphk9xfTJe @__Klok @ThrombosisRese1 https://t.co/rsb9PraMlh
-
Therapeutic versus prophylactic anticoagulation for severe #COVID19: https://t.co/UFO1JacBtk